| Mrs Danielle Renae Owens, APRN | |
|
211 E Stadium, Magnolia, AR 71753-2032 | |
| (870) 234-5995 | |
| Not Available |
| Full Name | Mrs Danielle Renae Owens |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 211 E Stadium, Magnolia, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467950501 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP2300X | Nurse Practitioner - Primary Care | A005458 (Arkansas) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | A005458 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Access Medical Clinic Arkansas Ltc Llc | 0547618175 | 96 |
News Archive
A Boston University School of Medicine study shows a mind-body class elective for medical students helps increase their self-compassion and ability to manage thoughts and tasks more effectively.
In stroke patients in whom intravenous thrombolysis is either contraindicated or has failed, intra-arterial revascularization with cerebral angioplasty and stent placement is an effective and well-tolerated treatment, say Czech researchers.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Pall Corporation (NYSE:PLL) today reported financial results for the fourth quarter and fiscal year ended July 31, 2009. Sales and net earnings for the year were $2.3 billion and $195.6 million, respectively. Diluted earnings per share (EPS) were $1.64, compared to $1.76 a year earlier. Pro forma EPS were $1.77 versus last year's $1.97.
› Verified 4 days ago
| Entity Name | Bradley Bibb Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699097436 PECOS PAC ID: 4789715285 Enrollment ID: O20100628000488 |
News Archive
A Boston University School of Medicine study shows a mind-body class elective for medical students helps increase their self-compassion and ability to manage thoughts and tasks more effectively.
In stroke patients in whom intravenous thrombolysis is either contraindicated or has failed, intra-arterial revascularization with cerebral angioplasty and stent placement is an effective and well-tolerated treatment, say Czech researchers.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Pall Corporation (NYSE:PLL) today reported financial results for the fourth quarter and fiscal year ended July 31, 2009. Sales and net earnings for the year were $2.3 billion and $195.6 million, respectively. Diluted earnings per share (EPS) were $1.64, compared to $1.76 a year earlier. Pro forma EPS were $1.77 versus last year's $1.97.
› Verified 4 days ago
| Entity Name | Access Medical Clinic Arkansas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578007647 PECOS PAC ID: 5890077093 Enrollment ID: O20170124001288 |
News Archive
A Boston University School of Medicine study shows a mind-body class elective for medical students helps increase their self-compassion and ability to manage thoughts and tasks more effectively.
In stroke patients in whom intravenous thrombolysis is either contraindicated or has failed, intra-arterial revascularization with cerebral angioplasty and stent placement is an effective and well-tolerated treatment, say Czech researchers.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Pall Corporation (NYSE:PLL) today reported financial results for the fourth quarter and fiscal year ended July 31, 2009. Sales and net earnings for the year were $2.3 billion and $195.6 million, respectively. Diluted earnings per share (EPS) were $1.64, compared to $1.76 a year earlier. Pro forma EPS were $1.77 versus last year's $1.97.
› Verified 4 days ago
| Entity Name | Urgent Care Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790291797 PECOS PAC ID: 3476818378 Enrollment ID: O20180524000325 |
News Archive
A Boston University School of Medicine study shows a mind-body class elective for medical students helps increase their self-compassion and ability to manage thoughts and tasks more effectively.
In stroke patients in whom intravenous thrombolysis is either contraindicated or has failed, intra-arterial revascularization with cerebral angioplasty and stent placement is an effective and well-tolerated treatment, say Czech researchers.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Pall Corporation (NYSE:PLL) today reported financial results for the fourth quarter and fiscal year ended July 31, 2009. Sales and net earnings for the year were $2.3 billion and $195.6 million, respectively. Diluted earnings per share (EPS) were $1.64, compared to $1.76 a year earlier. Pro forma EPS were $1.77 versus last year's $1.97.
› Verified 4 days ago
| Entity Name | Access Medical Clinic Arkansas Ltc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114578929 PECOS PAC ID: 0547618175 Enrollment ID: O20231208000065 |
News Archive
A Boston University School of Medicine study shows a mind-body class elective for medical students helps increase their self-compassion and ability to manage thoughts and tasks more effectively.
In stroke patients in whom intravenous thrombolysis is either contraindicated or has failed, intra-arterial revascularization with cerebral angioplasty and stent placement is an effective and well-tolerated treatment, say Czech researchers.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Pall Corporation (NYSE:PLL) today reported financial results for the fourth quarter and fiscal year ended July 31, 2009. Sales and net earnings for the year were $2.3 billion and $195.6 million, respectively. Diluted earnings per share (EPS) were $1.64, compared to $1.76 a year earlier. Pro forma EPS were $1.77 versus last year's $1.97.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Danielle Renae Owens, APRN 20 Columbia Road 525, Magnolia, AR 71753-8808 Ph: (870) 949-2718 | Mrs Danielle Renae Owens, APRN 211 E Stadium, Magnolia, AR 71753-2032 Ph: (870) 234-5995 |
News Archive
A Boston University School of Medicine study shows a mind-body class elective for medical students helps increase their self-compassion and ability to manage thoughts and tasks more effectively.
In stroke patients in whom intravenous thrombolysis is either contraindicated or has failed, intra-arterial revascularization with cerebral angioplasty and stent placement is an effective and well-tolerated treatment, say Czech researchers.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the company's New Drug Application (NDA) for eplivanserin (Ciltyri(R)). Eplivanserin was reviewed as a potential treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.
Pall Corporation (NYSE:PLL) today reported financial results for the fourth quarter and fiscal year ended July 31, 2009. Sales and net earnings for the year were $2.3 billion and $195.6 million, respectively. Diluted earnings per share (EPS) were $1.64, compared to $1.76 a year earlier. Pro forma EPS were $1.77 versus last year's $1.97.
› Verified 4 days ago
Andrew Woolfley, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 50 Highway 79 Byp N Ste C, Magnolia, AR 71753 Phone: 870-234-7435 Fax: 870-234-7476 | |
Haley M Quintana, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1617 N Washington # 599, Magnolia, AR 71753 Phone: 870-234-7676 Fax: 870-562-2559 | |
Ginger Ann Mulholland, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1920 South Washington, Magnolia, AR 71753 Phone: 870-949-2807 | |
Tara Almand, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 E University, Magnolia, AR 71753 Phone: 870-235-5254 Fax: 870-235-5263 | |
Mrs. Shawntel Marie Price, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1010 N Dudney Rd Ste C, Magnolia, AR 71753 Phone: 870-234-2675 Fax: 870-234-4153 | |
Mrs. Harriet Jean Alexander, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 104 Hospital Dr, Magnolia, AR 71753 Phone: 870-235-3555 Fax: 870-234-2149 | |
Ms. Callie Minter Sexton, FAMILY NURSE PRACTIT Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 207 W Calhoun, Magnolia, AR 71753 Phone: 870-235-3798 |